BACKGROUND: At our center, living donor liver transplantation (LDLT) is the main workload supported by a strong, mature service. Deceased donor liver transplantation (DDLT) is performed but in small volume. This study aimed to review the results of a low-volume DDLT service alongside a strong LDLT service. METHODS: Consecutive DDLTs for adults performed from 1991 to 2009 were reviewed. The 1st to the 50th DDLTs were categorized as Era I cases, and the rest were Era II cases. The outcomes of the DDLTs were analyzed and compared with those achieved overseas. RESULTS: Eras I and II consisted of 59 and 183 DDLTs, respectively. All donors were brain-dead and heart-beating with a median age of 49 years (range 7-76 years). Among the 242 DDLTS, 30.2 % were on a high-urgency basis and 15.3 % were for hepatocellular carcinoma. The patients had a median model for end-stage liver disease score of 21 (range 6-40), and most (67.8 %) were hepatitis B virus carriers. Before transplantation, 16.1 % of the patients were in the intensive care unit and 30.2 % were in the hospital. The hospital mortality rate dropped from 13.6 % (8/59) during Era I to 3.8 % (7/183) during Era II (p = 0.012). For Era I, the 1-, 3-, and 5-year survival rates were 84.7, 79.7, and 76.3 %, respectively, which improved to 92.9, 89.0 and 87.2 % for Era II (p = 0.026). CONCLUSIONS: The recipient survival of this series compares favorably with contemporary series. It is shown that a low-volume DDLT service alongside a strong LDLT service can have excellent results.
BACKGROUND: At our center, living donor liver transplantation (LDLT) is the main workload supported by a strong, mature service. Deceased donor liver transplantation (DDLT) is performed but in small volume. This study aimed to review the results of a low-volume DDLT service alongside a strong LDLT service. METHODS: Consecutive DDLTs for adults performed from 1991 to 2009 were reviewed. The 1st to the 50th DDLTs were categorized as Era I cases, and the rest were Era II cases. The outcomes of the DDLTs were analyzed and compared with those achieved overseas. RESULTS: Eras I and II consisted of 59 and 183 DDLTs, respectively. All donors were brain-dead and heart-beating with a median age of 49 years (range 7-76 years). Among the 242 DDLTS, 30.2 % were on a high-urgency basis and 15.3 % were for hepatocellular carcinoma. The patients had a median model for end-stage liver disease score of 21 (range 6-40), and most (67.8 %) were hepatitis B virus carriers. Before transplantation, 16.1 % of the patients were in the intensive care unit and 30.2 % were in the hospital. The hospital mortality rate dropped from 13.6 % (8/59) during Era I to 3.8 % (7/183) during Era II (p = 0.012). For Era I, the 1-, 3-, and 5-year survival rates were 84.7, 79.7, and 76.3 %, respectively, which improved to 92.9, 89.0 and 87.2 % for Era II (p = 0.026). CONCLUSIONS: The recipient survival of this series compares favorably with contemporary series. It is shown that a low-volume DDLT service alongside a strong LDLT service can have excellent results.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Balázs Nemes; Wojtek Polak; Gábor Ther; Herman Hendriks; László Kóbori; Robert J Porte; Enikõ Sárváry; Koert P de Jong; Attila Doros; Zsuzsa Gerlei; Aad P van den Berg; Imre Fehérvári; Dénes Görög; Paul M Peeters; Jenõ Járay; Maarten J H Slooff Journal: Transpl Int Date: 2006-05 Impact factor: 3.782
Authors: J B Cofer; G B Klintmalm; C V Morris; H Solomon; I A Watemberg; B S Husberg; L W Jennings Journal: Transplantation Date: 1992-05 Impact factor: 4.939
Authors: S Kawasaki; Y Hashikura; T Ikegami; Y Nakazawa; S Miwa; T Kubota; A Mita; M Terada; S Miyagawa; H Furukawa; S Todo; M Makuuchi Journal: J Hepatobiliary Pancreat Surg Date: 1999
Authors: See Ching Chan; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; William I Wei; Barbara Hsia-Ying Chik; John Wong Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Irene O Ng; Ching Lung Lai; John Wong Journal: Liver Transpl Date: 2004-06 Impact factor: 5.799
Authors: Michał Grąt; Karolina M Wronka; Waldemar Patkowski; Jan Stypułkowski; Karolina Grąt; Maciej Krasnodębski; Łukasz Masior; Zbigniew Lewandowski; Marek Krawczyk Journal: Dig Dis Sci Date: 2016-02 Impact factor: 3.199